{"id":54901,"date":"2023-03-16T12:05:29","date_gmt":"2023-03-16T11:05:29","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\/"},"modified":"2023-03-16T12:05:29","modified_gmt":"2023-03-16T11:05:29","slug":"applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\/","title":{"rendered":"Applied UV to Host Fourth Quarter and Year End 2022 Conference Call on April 3, 2023"},"content":{"rendered":"<div>\n<p>MOUNT VERNON, N.Y.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.applieduvinc.com%2F&amp;esheet=53361904&amp;newsitemid=20230316005031&amp;lan=en-US&amp;anchor=Applied+UV%2C+Inc.&amp;index=1&amp;md5=3d09e414ea83085ed8783bbcce9f4348\" rel=\"nofollow noopener\" shape=\"rect\">Applied UV, Inc.<\/a> (NasdaqCM: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Firdirect.net%2FAUVI&amp;esheet=53361904&amp;newsitemid=20230316005031&amp;lan=en-US&amp;anchor=AUVI&amp;index=2&amp;md5=d6c537afe7ff2c4dff6123293431db46\" rel=\"nofollow noopener\" shape=\"rect\">AUVI<\/a>) (\u201cApplied UV\u201d or the \u201cCompany\u201d), a global leading provider of patented, scientifically proven surface and air disinfection technologies encompassing fixed, mobile, and HVAC, with best-in-class LED lighting products and premium hotel furnishings, announced that the Company will be hosting an investor conference call and live webcast on Monday, April 3, 2023 at 9:00 am ET to review its financial results. Fourth quarter and year end 2022 financial results will be released after market close on Friday, March 31, 2023 and will be available through the Investor Relations section of the company&#8217;s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Firdirect.net%2FAUVI&amp;esheet=53361904&amp;newsitemid=20230316005031&amp;lan=en-US&amp;anchor=https%3A%2F%2Firdirect.net%2FAUVI&amp;index=3&amp;md5=433a2bd418c7e498364fa668f616f3a9\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/irdirect.net\/AUVI<\/a>.\n<\/p>\n<p>\n<b>Conference Call\/Webcast Information<\/b>\n<\/p>\n<p>\nApplied UV&#8217;s management team will host an investor conference call and live webcast on April 3, 2023, at 9:00 am ET. Investors can access the live webcast via a link on Applied UV&#8217;s web site or at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.webcaster4.com%2FWebcast%2FPage%2F2626%2F47804&amp;esheet=53361904&amp;newsitemid=20230316005031&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.webcaster4.com%2FWebcast%2FPage%2F2626%2F47804&amp;index=4&amp;md5=bd01bf0e048f9f3c591395d428f3a2e6\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.webcaster4.com\/Webcast\/Page\/2626\/47804<\/a>. For those planning to participate on the call, please dial +1-888-506-0062 (for domestic calls), or +1-973-528-0011 (for international calls), passcode 115108. A replay of the conference call will be available online on the Applied UV web site, and a dial-in replay will be available for one week following the call at +1-877-481-4010 (for domestic calls) or +1-919-882-2331 (for international calls), replay passcode 47804.\n<\/p>\n<p>\n<b>About Applied UV<\/b>\n<\/p>\n<p>\nApplied UV, Inc. (\u201cAUVI\u201d) provides proprietary surface and air disinfection technology focused on Improving Indoor Air Quality (IAQ), specialty LED lighting and luxury mirrors and commercial furnishings all of which serves clients globally in both the commercial and retail segments.\n<\/p>\n<p>\nOur products address the needs in the healthcare, hospitality, food preservation, cannabis, education, winery vertical markets. The Company has established strategic manufacturing partnerships and alliances including Canon, Acuity, Johnson Controls, Siemens, Grainger, and a global network of 64 dealers and distributors in 52 countries, offering a complete suite of products through its two wholly owned subsidiaries &#8211; SteriLumen, Inc. (\u201cSteriLumen\u201d) and Munn Works, LLC (\u201cMunn Works\u201d). SteriLumen owns brands and markets a portfolio of clinically proven products utilizing advanced UVC Carbon, Broad Spectrum UVC LED\u2019s, Photo-catalytic oxidation (PCO) pathogen elimination technology, branded Airocide <sup>\u00ae<\/sup>, Scientific Air\u2122, Airoclean\u2122 420, Lumicide\u2122, PUROHealth, PURONet, and LED Supply Company. Sterilumen\u2019s proprietary platform suite of patented, surface and air technologies offers, the most complete pathogen disinfection platform including mobile, fixed and HVAC systems and software solutions interconnecting its entire portfolio suite into the IoT allowing customers to implement, manage and monitor IAQ measures recommended by the EPA across any enterprise. Sterilumen\u2019s Lumicide\u2122 platform applies the power of ultraviolet light (UVC) to destroy pathogens automatically, addressing the challenge of healthcare-acquired infections (&#8220;HAI\u2019s) in several patented designs for infection control in healthcare. LED Supply Company, a full-service, wholesale distributor of LED lighting and controls throughout North America.\n<\/p>\n<p>\nMunnWorks manufactures and sells custom luxury and backlit mirrors, and conference room &amp; living spaces furnishings.\n<\/p>\n<p>\nOur global list of Fortune 100 end users including Kaiser Permanente, NY Health+Hospitals, MERCY Healthcare, Baptist Health South Florida, New York City Transit, Samsung, JB Hunt, Boston Red Sox\u2019s Fenway Park, JetBlue Park, France\u2019s Palace of Versailles, Whole Foods, Del Monte Foods, U.S. Department of Veterans Affairs, Marriott, Hilton, Four Seasons and Hyatt, and more. For information on Applied UV, Inc., and its subsidiaries, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.applieduvinc.com&amp;esheet=53361904&amp;newsitemid=20230316005031&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.applieduvinc.com&amp;index=5&amp;md5=30ae5320483b3220997527b88c0afbed\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.applieduvinc.com<\/a>\n<\/p>\n<p>\n<b>Forward-Looking Statements<\/b>\n<\/p>\n<p>\nThe information contained herein may contain \u201cforward\u2010looking statements.\u201d Forward\u2010looking statements reflect the current view about future events. When used in this press release, the words \u201canticipate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cfuture,\u201d \u201cintend,\u201d \u201cplan,\u201d or the negative of these terms and similar expressions, as they relate to us or our management, identify forward\u2010looking statements. Such statements include, but are not limited to, statements contained in this press release relating to the view of management of Applied UV concerning its business strategy, future operating results and liquidity and capital resources outlook. Forward\u2010looking statements are based on the Company\u2019s current expectations and assumptions regarding its business, the economy and other future conditions. Because forward\u2013looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company\u2019s actual results may differ materially from those contemplated by the forward\u2010looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward\u2010looking statements. Factors or events that could cause the Company\u2019s actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward\u2010looking statements to conform these statements to actual results.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nBrett Maas, Managing Principal<br \/>\n<br \/>Hayden IR<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;&#108;&#116;o&#x3a;&#x62;&#x72;&#101;&#116;t&#64;&#x68;&#x61;&#x79;&#100;&#101;n&#x69;&#x72;&#x2e;&#99;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x62;&#x72;&#x65;&#116;&#116;&#64;h&#x61;&#x79;&#x64;&#x65;&#110;&#105;r&#46;&#x63;&#x6f;&#x6d;<\/a><br \/>(646) 536-7331\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>MOUNT VERNON, N.Y.&#8211;(BUSINESS WIRE)&#8211;Applied UV, Inc. (NasdaqCM: AUVI) (\u201cApplied UV\u201d or the \u201cCompany\u201d), a global leading provider of patented, scientifically proven surface and air disinfection technologies encompassing fixed, mobile, and HVAC, with best-in-class LED lighting products and premium hotel furnishings, announced that the Company will be hosting an investor conference call and live webcast on &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54901","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Applied UV to Host Fourth Quarter and Year End 2022 Conference Call on April 3, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Applied UV to Host Fourth Quarter and Year End 2022 Conference Call on April 3, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MOUNT VERNON, N.Y.&#8211;(BUSINESS WIRE)&#8211;Applied UV, Inc. (NasdaqCM: AUVI) (\u201cApplied UV\u201d or the \u201cCompany\u201d), a global leading provider of patented, scientifically proven surface and air disinfection technologies encompassing fixed, mobile, and HVAC, with best-in-class LED lighting products and premium hotel furnishings, announced that the Company will be hosting an investor conference call and live webcast on ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-16T11:05:29+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Applied UV to Host Fourth Quarter and Year End 2022 Conference Call on April 3, 2023\",\"datePublished\":\"2023-03-16T11:05:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\\\/\"},\"wordCount\":835,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\\\/\",\"name\":\"Applied UV to Host Fourth Quarter and Year End 2022 Conference Call on April 3, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2023-03-16T11:05:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Applied UV to Host Fourth Quarter and Year End 2022 Conference Call on April 3, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Applied UV to Host Fourth Quarter and Year End 2022 Conference Call on April 3, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\/","og_locale":"en_US","og_type":"article","og_title":"Applied UV to Host Fourth Quarter and Year End 2022 Conference Call on April 3, 2023 - Pharma Trend","og_description":"MOUNT VERNON, N.Y.&#8211;(BUSINESS WIRE)&#8211;Applied UV, Inc. (NasdaqCM: AUVI) (\u201cApplied UV\u201d or the \u201cCompany\u201d), a global leading provider of patented, scientifically proven surface and air disinfection technologies encompassing fixed, mobile, and HVAC, with best-in-class LED lighting products and premium hotel furnishings, announced that the Company will be hosting an investor conference call and live webcast on ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-16T11:05:29+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Applied UV to Host Fourth Quarter and Year End 2022 Conference Call on April 3, 2023","datePublished":"2023-03-16T11:05:29+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\/"},"wordCount":835,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\/","url":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\/","name":"Applied UV to Host Fourth Quarter and Year End 2022 Conference Call on April 3, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2023-03-16T11:05:29+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/applied-uv-to-host-fourth-quarter-and-year-end-2022-conference-call-on-april-3-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Applied UV to Host Fourth Quarter and Year End 2022 Conference Call on April 3, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54901"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54901\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54901"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54901"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}